Efficacy and safety of one-month postpartum zidovudine and didanosine to prevent HIV-resistance mutations following intrapartum single-dose nevirapine

BACKGROUND: Intrapartum single-dose-nevirapine along with third trimester maternal and infant zidovudine are essential components of programs to prevent mother-to-child HIV transmission in resource-limited settings. The persistence of nevirapine in the plasma for three weeks postpartum risks selecti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lallemant, Marc, Ngo-Giang-Huong, Nicole, Jourdain, Gonzague, Traisaithit, Patrinee, Cressey, Tim R., Collins, Intira J., Jarupanich, Tapnarong, Sukhumanant, Thammanoon, Achalapong, Jullapong, Sabsanong, Prapan, Chotivanich, Nantasak, Winiyakul, Narong, Ariyadej, Surabon, Kanjanasing, Annop, Ratanakosol, Janyaporn, Hemvuttiphan, Jittapol, Kengsakul, Karun, Wannapira, Wiroj, Sittipiyasakul, Veerachai, Pornkitprasarn, Witaya, Liampongsabuddhi, Prateung, McIntosh, Kenneth, Van Dyke, Russell B., Frenkel, Lisa M., Koetsawang, Suporn, Le Coeur, Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2922986/
https://ncbi.nlm.nih.gov/pubmed/20158398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1086/650745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados